AVIR Atea Pharmaceuticals, Inc. logo

AVIR Atea Pharmaceuticals, Inc.

Healthcare
$4.42+4.25%ClosedMarket Cap: $353.7M

As of 2026-05-25

Insider Statistics (Q1 2026)

Acquisitions

14

Dispositions

13

Buy/Sell Ratio

1.08

Net Shares

+1,074,743

Shares Acquired

1,698,618

Shares Disposed

623,875

Total Bought ($)

$0.00

Total Sold ($)

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Thu May 21Murphy Polly A.directorBuy6,100$4.1792,145
Wed May 20Murphy Polly A.directorBuy6,100$4.1792,145
Fri Mar 13Corcoran Andreaofficer: See RemarksSell60,000$1.24823,576
Tue Feb 03Vavricka Johnofficer: Chief Commercial OfficerSell42,083$0.0094,164
Tue Feb 03Vavricka Johnofficer: Chief Commercial OfficerSell8,750$0.000
Tue Feb 03Vavricka Johnofficer: Chief Commercial OfficerSell11,570$4.2482,594
Tue Feb 03Vavricka Johnofficer: Chief Commercial OfficerSell119,520$4.24119,520
Tue Feb 03Horga Maria Arantxaofficer: Chief Medical OfficerSell51,283$0.00112,159
Tue Feb 03Horga Maria Arantxaofficer: Chief Medical OfficerSell9,750$0.000
Tue Feb 03Horga Maria Arantxaofficer: Chief Medical OfficerSell16,073$4.2496,086
Tue Feb 03Horga Maria Arantxaofficer: Chief Medical OfficerSell173,500$4.24173,500